BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

  June 2, 2026

   · 

  6 min read
• Press Releases

  Kazia Therapeutics Appoints James Levine as Chief Financial Officer

  June 2, 2026

   · 

  6 min read
• Press Releases

  Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

  June 2, 2026

   · 

  1 min read
• Press Releases

  Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events

  June 2, 2026

   · 

  4 min read
• Press Releases

  ENYO Pharma Appoints Jeff George as Chairman to Support Next Phase of Growth and Phase 3 Readiness

  June 2, 2026

   · 

  3 min read
• 

  Antibody-drug conjugate (ADC)

  ASCO: Merck overshadowed by upstart biotechs but TROP2 plans begin to pay off

  Merck may not have had the splashiest presentation at the American Society of Clinical Oncology meeting, but the data show why the Big Pharma remains king of oncology, analysts say.

  June 2, 2026

   · 

  4 min read

   · 

  Annalee Armstrong
• Press Releases

  Celcuity’s Gedatolisib Combination Regimens Doubled the Likelihood of Survival without Disease Progression or Death Compared to Alpelisib plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial in Patients with HR+/HER2- Advanced Breast Cancer

  June 2, 2026

   · 

  14 min read
• Press Releases

  Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer

  June 2, 2026

   · 

  11 min read
• Press Releases

  INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer’s Trial

  June 2, 2026

   · 

  10 min read
• Press Releases

  ProKidney Appoints Kenneth Locke as Chief Technical Officer

  June 2, 2026

   · 

  6 min read